SB 113 South Dakota Senate · 2022 Regular Session

add nabiximols as a Schedule III controlled substance.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2022

Committee Review

Feb 2022

Senate Passage

Feb 2022

House Passage

Governor

Introduced Jan 26, 2022 Last action Feb 7, 2022

Floor votes · Senate Feb 7, 2022

How they voted

31–3

Passed

Total votes 34

Feb 7, 2022

D Democratic3

2 Yea 1 Nay

66% Yea

R Republican31

29 Yea 2 Nay

93% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Total actions

Key actions

Committee

Feb 7, 2022

Senate · Passed

Senate Tabled , Passed, YEAS 32, NAYS 3 S.J. 196

Feb 4, 2022

Senate · Passed

Senate Deferred to another day , Passed, S.J. 182

Feb 3, 2022

Senate · Reported by committee

Judiciary Do Pass , Passed, YEAS 4, NAYS 2

Jan 26, 2022

Senate · Introduced

First read in Senate and referred to S.J. 115

3 primary · 0 co-sponsors